ENTERPRISE FINANCIAL SERVICES CORP - TARO PHARMACEUTICAL INDS LTD ownership

TARO PHARMACEUTICAL INDS LTD's ticker is TARO and the CUSIP is M8737E108. A total of 69 filers reported holding TARO PHARMACEUTICAL INDS LTD in Q1 2022. The put-call ratio across all filers is 2.50 and the average weighting 0.2%.

Quarter-by-quarter ownership
ENTERPRISE FINANCIAL SERVICES CORP ownership history of TARO PHARMACEUTICAL INDS LTD
ValueSharesWeighting
Q4 2021$21,000
-19.2%
4100.0%0.00%0.0%
Q3 2021$26,000
-13.3%
4100.0%0.00%
-40.0%
Q2 2021$30,0000.0%4100.0%0.01%0.0%
Q1 2021$30,0000.0%4100.0%0.01%
-16.7%
Q4 2020$30,000
+36.4%
4100.0%0.01%
+20.0%
Q3 2020$22,000
-18.5%
4100.0%0.01%
-16.7%
Q2 2020$27,000
+8.0%
4100.0%0.01%0.0%
Q1 2020$25,000
-30.6%
4100.0%0.01%
-25.0%
Q4 2019$36,000
+16.1%
4100.0%0.01%
+14.3%
Q3 2019$31,000
-11.4%
4100.0%0.01%
-12.5%
Q2 2019$35,000
-20.5%
4100.0%0.01%
-20.0%
Q1 2019$44,000
+780.0%
410
+831.8%
0.01%
+400.0%
Q4 2017$5,0000.0%440.0%0.00%0.0%
Q3 2017$5,0000.0%440.0%0.00%0.0%
Q2 2017$5,00044
+1000.0%
0.00%
Q1 2017$0
-100.0%
4
-86.7%
0.00%
-100.0%
Q4 2016$3,000300.00%
Other shareholders
TARO PHARMACEUTICAL INDS LTD shareholders Q1 2022
NameSharesValueWeighting ↓
HealthInvest Partners AB 78,905$8,306,0007.65%
FORT, L.P. 157,584$16,589,0004.68%
MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC 808,200$85,079,0004.39%
Strategic Global Advisors, LLC 81,432$8,572,0003.18%
Prince Street Capital Management LLC 48,700$5,127,0001.62%
Analyst IMS Investment Management Services Ltd. 31,438$3,309,0001.45%
Freestone Capital Holdings, LLC 84,900$8,937,0000.77%
RPG Investment Advisory, LLC 17,227$1,813,0000.61%
CLINTON GROUP INC 46,370$4,881,0000.28%
USA FINANCIAL FORMULAS 10,786$1,135,0000.28%
View complete list of TARO PHARMACEUTICAL INDS LTD shareholders